吸入麻酔市場：製品別、用途別、エンドユーザー別、地域別

吸入麻酔の市場規模は、2025年には14億8,360万米ドルと推定され、2032年には21億2,970万米ドルに達すると予測され、2025～2032年までのCAGRは5.3％を示します。

吸入麻酔薬（亜酸化窒素、ハロタン、イソフルラン、デスフルラン、セボフルランなど現在最も一般的に使用されている薬剤）は、手術室での全身麻酔の導入と維持に使用されます。吸入麻酔薬は、麻酔状態をより正確にコントロールでき、低コストで行えるため、麻酔の維持に好まれています。

市場力学

慢性疾患の有病率の増加、高齢者人口の増加、緊急症例と外科的介入の増加、吸入麻酔の需要増加、COVID-19（パンデミック）の発生は、予測期間中に世界の吸入麻酔市場の成長を増大させると予想される主な要因です。

例えば、2022年8月、複合病院向けジェネリック医薬品の主要企業であるPiramal Pharma Limitedのクリティカルケア事業は、硫酸亜鉛注射液の米国市場初ジェネリック発売を発表しました。本製品は、米国食品医薬品局（FDA）より競合ジェネリック医薬品（Competitive Generic Therapy）として承認されています。30mg/10mL（3mg/mL）と25mg/5mL（5mg/mL）があります。

本調査の主な特徴

• 本レポートは、世界の吸入麻酔市場を詳細に分析し、2024年を基準年とした予測期間2025～2032年の市場規模および複合年間成長率（CAGR）を提供します。
• また、異なるセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて、世界の吸入麻酔市場の主要企業プロファイルを掲載しています。
• このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
• 世界の吸入麻酔市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の吸入麻酔市場の分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

目次：

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 慢性疾患の増加、高齢化の進展
  • 副作用とジェネリック医薬品の需要増加
  • 新しい吸入麻酔薬の需要または使用の増加
• 影響分析
• 主なハイライト
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ

第4章 世界の吸入麻酔市場：製品別、2020～2032年

• セボフルラン
• デスフルラン
• イソフルラン
• 亜酸化窒素

第5章 世界の吸入麻酔市場：用途別、2020～2032年

• 導入
• 維持

第6章 世界の吸入麻酔市場：エンドユーザー別、2020～2032年

• 病院
• 外来手術センター

第7章 世界の吸入麻酔市場：地域別、2020～2032年

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• Abbvie Inc.
• Novartis AG
• Piramal Enterprises Ltd.
• Hikma Pharmaceuticals Plc
• Fresenius SE & CO. KGaA
• Baxter International Inc.
• Troikaa Pharmaceuticals, Ltd.
• Halocarbon Products Corporation
• Jiangsu Hengrui Medicine Co., Ltd.
• Lunan Pharmaceutical Group Co. Ltd.

第9章 セクション

• 調査手法
• 出版社について

Inhalation Anesthesia Market size is estimated to be valued at USD 1,483.6 Mn in 2025 and is expected to reach USD 2,129.7 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

Inhalation anesthetics (such as nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane; most commonly used agents in practice today) are used for induction and maintenance of general anesthesia in the operating room. Inhaled anesthetics are preferred for maintenance of anesthesia because they allow a more precise control of the anesthetic state and do so at low cost.

Market Dynamics

Increasing prevalence of chronic disease, growing geriatric (aging) population, increasing number of emergency cases and surgical interventions, increase in demand for inhalation anesthesia, and outbreak of COVID-19 (pandemic) are major factors expected to augment the growth of the global inhalation anesthesia market during the forecast period.

For instance, in August 2022, Piramal Pharma Limited's Critical Care business, a leading Complex Hospital Generics company, announced the First to Market Generic U.S. launch of the Zinc Sulfate Injection. This product is U.S. Food and Drug Administration approved with Competitive Generic Therapy (CGT) designation; an approval pathway intended to enhance market competition for sole source drugs. The injection is available in 30mg/10mL (3mg/mL) and 25mg/5mL (5mg/mL).

Key features of the study

• This report provides in-depth analysis of the global inhalation anesthesia market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global inhalation anesthesia market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbvie Inc., Novartis AG, Piramal Enterprises Ltd., Hikma Pharmaceuticals Plc, Fresenius SE & CO. KGaA, Halocarbon Products Corporation, Baxter International Inc., Troikaa Pharmaceuticals, Ltd., Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global inhalation anesthesia market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhalation anesthesia market.

Detailed Segmentation

• Global Inhalation Anesthesia Market, By Product
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide
• Global Inhalation Anesthesia Market, By Application
  • Induction
  • Maintenance
• Global Inhalation Anesthesia Market, By End User
  • Hospitals
  • Ambulatory Surgical Centers
• Global Inhalation Anesthesia Market, By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles
  • Abbvie Inc.
  • Novartis AG
  • Piramal Enterprises Ltd.
  • Hikma Pharmaceuticals Plc
  • Fresenius SE & CO. KgaA
  • Baxter International Inc.
  • Troikaa Pharmaceuticals, Ltd.
  • Halocarbon Products Corporation
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Lunan Pharmaceutical Group Co. Ltd.

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • High burden of chronic disease and growing geriatric population
  • Side-effects and rise in demand or adoption of generic drugs
  • Increasing demand or use of novel inhalation anesthetic drugs
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Inhalation Anesthesia Market, By Product, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Sevoflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Desflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Isoflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Nitrous Oxide
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

5. Global Inhalation Anesthesia Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Induction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Maintenance
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Inhalation Anesthesia Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Inhalation Anesthesia Market, By Geography, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)

8. Competitive Landscape

• Abbvie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Piramal Enterprises Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hikma Pharmaceuticals Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fresenius SE & CO. KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Troikaa Pharmaceuticals, Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Halocarbon Products Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jiangsu Hengrui Medicine Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lunan Pharmaceutical Group Co. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us